Buy or sell Accelus stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Accelus Stock

Accelus is an minimally invasive spine surgery through its procedure-enabling technology.

About Accelus Stock

Accelus is committed to accelerating minimally invasive spine surgery through its procedure-enabling technology with broad accessibility to previously underserved markets.

Management

Chief Executive Officer & Co-Founder

Christopher Walsh

Chief Strategy Officer (CSO)

Andrew Wolf

Director of Clinical Research

Rachelle Yusufbekov

Chief Robotics Officer

Kevin T. Foley

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo